OneSource Specialty (ONESOURCE) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
14.4B
Gross Profit
10.1B
69.89%
Operating Income
1.9B
13.33%
Net Income
-179.7M
-1.24%
Balance Sheet Metrics
Total Assets
75.5B
Total Liabilities
16.7B
Shareholders Equity
58.8B
Debt to Equity
0.28
Cash Flow Metrics
Operating Cash Flow
-2.2B
Free Cash Flow
-2.0B
Revenue & Profitability Trend
OneSource Specialty Income Statement From 2023 to 2025
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 14.4B | 1.7B | 387.1M |
| Cost of Goods Sold | 4.4B | 705.1M | 204.1M |
| Gross Profit | 10.1B | 1.0B | 183.0M |
| Operating Expenses | 3.3B | 1.3B | 911.5M |
| Operating Income | 1.9B | -1.6B | -2.2B |
| Pre-tax Income | -670.7M | -3.7B | -4.2B |
| Income Tax | -497.8M | 0 | 0 |
| Net Income | -179.7M | -3.9B | -8.0B |
| EPS (Diluted) | - | -₹94.15 | -₹192.51 |
Income Statement Trend
OneSource Specialty Balance Sheet From 2023 to 2025
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Current Assets | 10.9B | 1.8B | 2.3B |
| Non-Current Assets | 64.6B | 11.3B | 17.8B |
| Total Assets | 75.5B | 13.1B | 20.1B |
| Liabilities | |||
| Current Liabilities | 11.1B | 6.3B | 8.7B |
| Non-Current Liabilities | 5.6B | 2.8B | 3.6B |
| Total Liabilities | 16.7B | 9.1B | 12.2B |
| Equity | |||
| Total Shareholders Equity | 58.8B | 4.0B | 7.9B |
Balance Sheet Composition
OneSource Specialty Cash Flow Statement From 2023 to 2025
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -677.6M | -3.9B | -8.0B |
| Operating Cash Flow | -2.2B | -3.3B | -6.7B |
| Investing Activities | |||
| Capital Expenditures | - | - | - |
| Investing Cash Flow | -861.6M | 5.7B | -268.7M |
| Financing Activities | |||
| Dividends Paid | - | - | - |
| Financing Cash Flow | 5.9B | -4.1B | 2.3B |
| Free Cash Flow | -2.0B | -1.7B | -2.1B |
Cash Flow Trend
OneSource Specialty Key Financial Ratios
Valuation Ratios
Forward P/E
31.00
Price to Book
3.89
Price to Sales
15.85
Profitability Ratios
Profit Margin
-1.24%
Operating Margin
26.77%
Return on Equity
-0.55%
Return on Assets
2.72%
Financial Health
Current Ratio
0.98
Debt to Equity
16.03
Per Share Data
EPS (TTM)
-₹1.60
Book Value per Share
₹514.02
Revenue per Share
₹131.05
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| onesource | 229.1B | - | 3.89 | -0.55% | -1.24% | 16.03 |
| Biocon | 492.9B | 43.71 | 2.04 | 5.40% | 6.64% | 66.26 |
| Concord Biotech | 192.1B | 51.74 | 10.60 | 22.26% | 30.97% | 0.16 |
| Blue Jet Healthcare | 162.2B | 51.72 | 13.95 | 30.86% | 29.63% | 1.76 |
| Supriya Lifescience | 56.5B | 29.90 | 5.60 | 20.74% | 26.99% | 0.54 |
| Dishman Carbogen | 40.6B | 1,233.57 | 0.70 | 0.06% | 0.12% | 40.97 |
Financial data is updated regularly. All figures are in the company's reporting currency.